Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 27;29(20):4256–4267. doi: 10.1158/1078-0432.CCR-23-0538

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©2023 The Authors; Published by the American Association for Cancer Research

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

PMC Copyright notice

Figure 5. Prognostic effect of genomic and transcriptomic analyses on MDSRS+ outcome. EFS stratified by genomic (A), transcriptomic classification (B), and estimated MEP percentage (C) in all MDSRS+ (A–C) and MDS-RS-SLD/MLD only (D–F). Multivariable Cox proportional hazard model for EFS in all MDSRS+ including age, IPSS-M score, and estimated MEP percentage as continuous variables (G). EFS stratified by estimated MEP percentage and IPSS-M risk category (H and I) (full representation of the six IPSS-M categories shown in Supplementary Fig. S21A). — Prognostic effect of genomic and transcriptomic analyses on MDS^RS+ outcome. EFS stratified by genomic (A), transcriptomic classification (B), and estimated MEP percentage (C) in all MDS^RS+ (A–C) and MDS-RS-SLD/MLD only (D–F). Multivariable Cox proportional hazard model for EFS in all MDS^RS+ including age, IPSS-M score, and estimated MEP percentage as continuous variables (G). EFS stratified by estimated MEP percentage and IPSS-M risk category (H and I) (full representation of the six IPSS-M categories shown in Supplementary Fig. S21A).